Where the Global CNS Oligo Community Unite
With companies such as Eli Lilly, Alnylam, and Stoke progressing deeper into clinical trials and innovation in the preclinical space continues to advance in leaps and bounds through 2nd generation BBB shuttles, novel chemistry optimization and conjugated oligos it’s the prime time to bring together the community once again for the 6th Oligos for CNS Summit.
Join 160+ peers from discovery biology, oligo chemistry, PK/PD, delivery to discuss, strategize and gain actionable insights for end-to-end development of oligos for CNS indications such as Parkinsons, pain, ALS & more.
Unmissable Event Highlights
Join a workshop with Stoke Therapeutics to uncover the mechanistic edge of ASOs, explore reshaping RNA processing, restoring functional protein output, and rebalancing isoform expression, while defining what true success looks like in ASO programs
Discover how CNS-targeting oligonucleotides are moving beyond rare diseases into broader indications and what this shift means for delivery strategies, scalable manufacturing, and an increasingly competitive landscape
Dive into Eli Lilly’s Parkinson’s program, with a closer look at clinical trial design, including target engagement, dose escalation, safety insights, and long-term study outcomes shaping their strategy
Join a panel discussion on the evolving toolkit for CNS oligo delivery spanning AAVs, peptides, lipids, and innovative BBB modulation techniques, with expert perspectives from D2B3 and Voyager Therapeutics
Hear how Gatehouse Bio is leveraging AI-driven microRNA discovery to identify precise oligo targets in the CNS, unlocking new opportunities tied to distinct disease pathways and progression
Explore the Full Event Guide
- Explore 3 days of highly technical, data-driven discussions addressing the challenges unique to CNS development
- Preview 5+ sessions containing brand-new data
- Explore unmissable networking opportunities, including roundtable discussions and a poster session
- Preview the audience composition and seniority from last year’s event
- Share easily with your team to assess and mobilise interest
Attending Companies Include
Join 160+ CNS Oligo Experts
Be part of leading discussions with your peers spanning end-to-end development of siRNAs, ASOs, aptamers and more.
Showcase Your Solutions
Align your brand with leading innovators and gain visibility in a space defined by active engagement and strategic partnerships.
Explore the Brand-New Agenda
Immerse in fresh data drops, breakthrough approaches in CNS delivery, and a program built to spark conversations.